ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $136,000 | +14.3% | 33,236 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $119,000 | -1.7% | 33,236 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $121,000 | -16.6% | 33,236 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $145,000 | +5.8% | 33,236 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $137,000 | -6.2% | 33,236 | -9.3% | 0.01% | -16.7% |
| Q4 2020 | $146,000 | +8.1% | 36,656 | -26.9% | 0.01% | 0.0% |
| Q3 2020 | $135,000 | – | 50,179 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |